Abstract
Transient Receptor Potential Vanilloid Type 1 is a prominent “pain” receptor expressed in sensory afferent neurons. TRPV1 on peripheral nerve terminals detects a variety of noxious stimuli generated at sites of injury and inflammation, and in turn, drives the excitation and sensitization of C-fiber neurons. Significantly, TRPV1 is also located on the central terminals of sensory neurons projecting to the spinal cord and brainstem. These TRPV1 channels appear to stimulate the secretion of glutamate. Further, TRPV1 is expressed diffusely in the brain and there is emerging evidence for TRPV1 modulating transmission at various brain synapses. Here we discuss our current understanding of the potential roles for TRPV1 in synaptic transmission.
Keywords: Brain, CNS, pain, presynaptic, spinal cord, TRPV1, Synaptic Transmission, sensory afferent neurons, capsaicin, synaptophysin, noxious stimuli, amygdala, periaqueductal gray, TRPV1 mRNA, tetrodotoxin, vanilloids, eicosanoids, (PKC) activation, PIP2, mEPSCs, TRPV1 channels, PKC stimulation, hippocampal neurons, presynaptic dopamine receptors, EPSC amplitude, endovanilloids, dopaminergic neurons, GABAergic transmission, nociceptive responses, neurohypophysis, capsazepine, PLC signaling
Current Pharmaceutical Biotechnology
Title: TRPV1 and Synaptic Transmission
Volume: 12 Issue: 1
Author(s): Jose A. Matta and Gerard P. Ahern
Affiliation:
Keywords: Brain, CNS, pain, presynaptic, spinal cord, TRPV1, Synaptic Transmission, sensory afferent neurons, capsaicin, synaptophysin, noxious stimuli, amygdala, periaqueductal gray, TRPV1 mRNA, tetrodotoxin, vanilloids, eicosanoids, (PKC) activation, PIP2, mEPSCs, TRPV1 channels, PKC stimulation, hippocampal neurons, presynaptic dopamine receptors, EPSC amplitude, endovanilloids, dopaminergic neurons, GABAergic transmission, nociceptive responses, neurohypophysis, capsazepine, PLC signaling
Abstract: Transient Receptor Potential Vanilloid Type 1 is a prominent “pain” receptor expressed in sensory afferent neurons. TRPV1 on peripheral nerve terminals detects a variety of noxious stimuli generated at sites of injury and inflammation, and in turn, drives the excitation and sensitization of C-fiber neurons. Significantly, TRPV1 is also located on the central terminals of sensory neurons projecting to the spinal cord and brainstem. These TRPV1 channels appear to stimulate the secretion of glutamate. Further, TRPV1 is expressed diffusely in the brain and there is emerging evidence for TRPV1 modulating transmission at various brain synapses. Here we discuss our current understanding of the potential roles for TRPV1 in synaptic transmission.
Export Options
About this article
Cite this article as:
A. Matta Jose and P. Ahern Gerard, TRPV1 and Synaptic Transmission, Current Pharmaceutical Biotechnology 2011; 12 (1) . https://dx.doi.org/10.2174/138920111793937925
DOI https://dx.doi.org/10.2174/138920111793937925 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Further Vitamin D Analogs
Current Vascular Pharmacology Editorial [Hot Topic: Food and Addiction: Implications and Relevance to Eating Disorders and Obesity (Guest Editor: Nicole M. Avena)]
Current Drug Abuse Reviews The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies
Current Neuropharmacology 2-Arylbenzothiazole as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Emergence of Sexual Dreams and Emission Following Deep Transcranial Magnetic Stimulation over the Medial Prefrontal and Cingulate Cortices
CNS & Neurological Disorders - Drug Targets Paramutation: Just a Curiosity or Fine Tuning of Gene Expression in the Next Generation?
Current Genomics Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer’s Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice
Current Alzheimer Research Drug Metabolism as an Object of Computational Analysis by the Monte Carlo Method
Current Drug Metabolism Effects of Gene and Plasma Tau on Cognitive Impairment in Rural Chinese Population
Current Alzheimer Research 5-Methoxy-1-methyl-2-{[4-(2-hydroxyphenyl)piperazin-1-yl]methyl}-1Hindole (KAD22) with Antioxidant Activity
Letters in Organic Chemistry Amyloid Beta: The Alternate Hypothesis
Current Alzheimer Research The Etiology of Hypertension in the Metabolic Syndrome Part Four: The Systemic Perspective – The Role of the Neuroendocrine and Immune Systems,and the Challenge of Integration
Current Vascular Pharmacology Alcohol Addiction- Metabotropic Glutamate Receptor Subtype 5 and its Ligands: How They All Come Together?
Current Drug Targets Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews Engineering of Conotoxins for the Treatment of Pain
Current Pharmaceutical Design Editorial [Hot topic: Adenosine Receptor Ligands: Where Are We, and Where Are We Going? (Guest Editors: Tiziano Tuccinardi and Adriano Martinelli)]
Current Topics in Medicinal Chemistry Oral Disintegrating Tablets – An Updated Patent Perspective
Recent Patents on Drug Delivery & Formulation Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets Physiological and Non-Redundant Functions of PKC Isotypes in T Lymphocytes
Current Immunology Reviews (Discontinued)